Log In
Log In
Client Account Access
Equity Research Access
Fixed Income Client Portal
Macro Research Access
Merchant Banking Investor Access
Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy & Power
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
Insights
News
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Read more
about NovanInc-2018-01-05
$38.0 Million
Image
Novan, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
Read more
about OcularTherapeutixInc-2018-01-25
$37.4 Million
Image
Ocular Therapeutix, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
Read more
about CatalystPharmaceuticalsInc-2017-11-28
$57.5 Million
Image
Catalyst Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
Read more
about ProthenaCorporationplc-2021-09-27
$250.0 Million
Image
Prothena Corporation plc
At the Market Offering
Left Bookrunner
Read more
about FulgentGeneticsInc-2019-08-30
$45.0 Million
Image
Fulgent Genetics, Inc.
At the Market Offering
Left Bookrunner
Read more
about FulgentGeneticsInc-2020-09-24
$125.0 Million
Image
Fulgent Genetics, Inc.
At the Market Offering
Left Bookrunner
Read more
about FulgentGeneticsInc-2020-11-20
$175.0 Million
Image
Fulgent Genetics, Inc.
At the Market Offering
Left Bookrunner
Read more
about FulgentGeneticsInc-2019-11-13
$30.0 Million
Image
Fulgent Genetics, Inc.
Follow-On Offering
Left Bookrunner
Read more
about SoloBrands-2021-10-27
$252.0 Million
Image
Solo Brands
Initial Public Offering
Left Bookrunner
Read more
about HuamiCorp-2018-02-08
Image
Huami Corp
Initial Public Offering
Left Bookrunner
Pagination
Previous page
‹‹
Page 10
Next page
››
Subscribe to Left Bookrunner